Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07255443

Enrollment

120

Registered

2025-12-01

Start date

2026-02-01

Completion date

2027-06-05

Last updated

2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rate of Carbapenemase Intestinal Carrier Inside ICU

Brief summary

significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.

Interventions

OTHERObservational study

Observational study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults (≥18 years)\_ * Expected ICU stay ≥48 hours -

Exclusion criteria

* .ICU stay \<48 hours

Design outcomes

Primary

Measure	Time frame
rate of intestinal colonization with CRE	One year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026